source
- GSK CEO warns possible team reorganization if upcoming Phase 3 readouts fall shortGSK's chief executive Luke Miels told analysts during the first‑quarter earnings call that the company has several pivotal Phase 3 trials slated for this year. He said that if those late‑stage rea…
- Supreme Court hints skinny labeling may remain viable for generic drugsAt a hearing, Supreme Court justices heard arguments about skinny labeling, a practice used by generic manufacturers to seek approval for a subset of a brand drug's indications. The justices did n…